Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies.

× No keyword cloud information.

5 in total

1. Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies.

Authors: Emilien Delmont; P Y Jeandel; C Benaïm; E Rosenthal; J G Fuzibet; C Desnuelle
Journal: J Neurol Date: 2011-03-25 Impact factor: 4.849

2. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy.

Authors: Jean-Marc Léger; Karine Viala; Guillaume Nicolas; Alain Créange; Jean-Michel Vallat; Jean Pouget; Pierre Clavelou; Christophe Vial; Andreas Steck; Lucile Musset; Benoit Marin
Journal: Neurology Date: 2013-05-10 Impact factor: 9.910

3. Entrapment in anti myelin-associated glycoprotein neuropathy.

Authors: Catharina G Faber; Nicolette C Notermans; John H J Wokke; Hessel Franssen
Journal: J Neurol Date: 2009-03-18 Impact factor: 4.849

4. GSK249320, A Monoclonal Antibody Against the Axon Outgrowth Inhibition Molecule Myelin-Associated Glycoprotein, Improves Outcome of Rodents with Experimental Stroke.

Authors: Diana Cash; Alanna C Easton; Michel Mesquita; John Beech; Steve Williams; Andrew Lloyd; Elaine Irving; Steven C Cramer
Journal: J Neurol Exp Neurosci Date: 2016-11-21

Review 5. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.

Authors: Marinos C Dalakas
Journal: Ther Adv Neurol Disord Date: 2018-01-15 Impact factor: 6.570

5 in total